Page last updated: 2024-11-02

oxyphenbutazone and Facial Injuries

oxyphenbutazone has been researched along with Facial Injuries in 1 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Facial Injuries: General or unspecified injuries to the soft tissue or bony portions of the face.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thion, A1
Tessier, P1

Other Studies

1 other study available for oxyphenbutazone and Facial Injuries

ArticleYear
[Clinical study of Tanderil in maxillofacial and plastic surgery].
    Annales de chirurgie plastique, 1973, Volume: 18, Issue:1

    Topics: Adolescent; Child; Cleft Lip; Coloboma; Face; Facial Bones; Facial Injuries; Facial Neoplasms; Femal

1973